rivaroxaban-based antithrombotic strategy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rivaroxaban-based antithrombotic strategy, covering 2020-01-13 to 2020-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes [Phase 3]